IL1B and breast cancer: Irena et al. (Kaplanov et al., 2019) indicated that the particular importance to tumor-mediated inflammation is IL-1β, IL-1β is increased in most cancers, including breast cancer in advanced stages, where it is mainly expressed by cells in the microenvironment and enhances progression and metastasis.